Skip to main content

Advertisement

Fig. 2 | Arthritis Research & Therapy

Fig. 2

From: Risk factors for flare and treatment of disease flares during pregnancy in rheumatoid arthritis and axial spondyloarthritis patients

Fig. 2

Response to treatment of flares with tumor necrosis factor inhibitor (TNFi) or glucocorticosteroid (GC) treatment in patients with rheumatoid arthritis (RA) and axial spondyloarthritis (axSpA) during pregnancy. The upper panels show the time course of C-reactive protein (CRP) levels in patients with RA in whom TNFi treatment (a) or GC treatment (b) was initiated during pregnancy. The lower panels show the time course of CRP levels in patients with axSpA in whom TNFi treatment (c) or GC treatment (d) was initiated during pregnancy. Box plots present the medians and the interquartile ranges. *P < 0.05

Back to article page